Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥569.0bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥1.11T2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥546.0bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥44.4bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥44.4bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥43.3bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥76.0bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥43.4bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥44.3bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥48.1bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥26.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥50.7bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥27.9bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥29.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥30.4bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥1.18Tat 2024-09-30Cons.Assets
Total assets¥1.21Tat 2024-03-31Cons.Assets
Total assets¥1.21Tat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥401.2bnat 2024-09-30Cons.Liabilities
Total liabilities¥417.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥774.6bnat 2024-09-30Cons.Net assets
Net assets / equity¥787.8bnat 2024-03-31Cons.Net assets
Net assets / equity¥786.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥78.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥106.9bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥73.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥102.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥78.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥60.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥108.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥25.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥12.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥24.6bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥17.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥43.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥97.662024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.642023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.132023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio61.9%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio61.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥318m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥318m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥1.8bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2024-04-01 → 2024-09-30¥455.4bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2024-04-01 → 2024-09-30¥455.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥307m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2024-04-01 → 2024-09-30¥27.6bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2024-04-01 → 2024-09-30¥113.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2024-04-01 → 2024-09-30¥113.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥10m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2024-04-01 → 2024-09-30¥18.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥569.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥569.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥318m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥46.2bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥303m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥303m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2023-04-01 → 2023-09-30¥445.5bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2023-04-01 → 2023-09-30¥445.2bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥293m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2023-04-01 → 2023-09-30¥29.7bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2023-04-01 → 2023-09-30¥100.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2023-04-01 → 2023-09-30¥100.8bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥9m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2023-04-01 → 2023-09-30¥15.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥546.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥546.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥303m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥45.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 542
ItemContextValueUnit
Loss on retirement of property plant and equipment ope cfCurrentYTDDuration1135000000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration31000000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-77000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration-858000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration-508000000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration366000000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration-564000000JPY
Interest and dividends income ope cfPrior1YTDDuration-974000000JPY
Interest and dividends income ope cfCurrentYTDDuration-830000000JPY
Interest expenses ope cfPrior1YTDDuration202000000JPY
Interest expenses ope cfCurrentYTDDuration173000000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration1521000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration2221000000JPY
Loss gain on sales of property plant and equipment ope cfPrior1YTDDuration-1466000000JPY
Loss gain on sales of property plant and equipment ope cfCurrentYTDDuration-526000000JPY
Loss gain on sales of investment securities ope cfPrior1YTDDuration-3028000000JPY
Loss gain on sales of investment securities ope cfCurrentYTDDuration-3483000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-39918000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration244000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-2926000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-21692000000JPY
Increase decrease in contract liabilities ope cfPrior1YTDDuration-346000000JPY
Increase decrease in contract liabilities ope cfCurrentYTDDuration227000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration9734000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-23543000000JPY
Other net ope cfPrior1YTDDuration-4542000000JPY
Other net ope cfCurrentYTDDuration-6655000000JPY
Subtotal ope cfPrior1YTDDuration34705000000JPY
Subtotal ope cfCurrentYTDDuration18114000000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration1176000000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration1500000000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-230000000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-173000000JPY
Income taxes paid ope cfPrior1YTDDuration-9751000000JPY
Income taxes paid ope cfCurrentYTDDuration-15681000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration25899000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration3760000000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-23333000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-33114000000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-1719000000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-2244000000JPY
Proceeds from sales of property plant and equipment and intangible assets inv cfPrior1YTDDuration1721000000JPY
Proceeds from sales of property plant and equipment and intangible assets inv cfCurrentYTDDuration1497000000JPY
Subsidies received inv cfPrior1YTDDuration532000000JPY
Subsidies received inv cfCurrentYTDDuration2425000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-285000000JPY
Purchase of investment securities inv cfCurrentYTDDuration-102000000JPY
Proceeds from sales of investment securities inv cfPrior1YTDDuration3699000000JPY
Proceeds from sales of investment securities inv cfCurrentYTDDuration20641000000JPY
Other net inv cfPrior1YTDDuration4069000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass